3/9
04:29 pm
chrs
Coherus BioSciences Non-GAAP EPS of -$0.34 misses by $0.03, revenue of $12.7M misses by $1.39M [Seeking Alpha]
Medium
Report
Coherus BioSciences Non-GAAP EPS of -$0.34 misses by $0.03, revenue of $12.7M misses by $1.39M [Seeking Alpha]
3/9
04:15 pm
chrs
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
3/2
09:30 am
chrs
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
Medium
Report
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
2/23
09:30 am
chrs
Coherus Oncology to Participate in Upcoming Investor Conferences
Low
Report
Coherus Oncology to Participate in Upcoming Investor Conferences
2/17
04:11 pm
chrs
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
Low
Report
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
2/12
09:18 pm
chrs
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
Medium
Report
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
2/12
04:05 pm
chrs
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
High
Report
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
1/22
05:08 pm
chrs
Coherus Oncology (NASDAQ:CHRS) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
High
Report
Coherus Oncology (NASDAQ:CHRS) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
1/16
08:00 am
chrs
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
Medium
Report
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
1/6
09:30 am
chrs
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/6
08:27 am
chrs
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer [Yahoo! Finance]
High
Report
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer [Yahoo! Finance]
1/6
08:00 am
chrs
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer
Medium
Report
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer
1/5
09:30 am
chrs
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
Medium
Report
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)